Impact of Age and Sex on Coronary Flow Reserve and Microvascular Function in Patients With Angina and Nonobstructive

Spyridon Kostantinis1, Gabriel Garcia Castro1, Nida Latif2

  • 1Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.

Insights

Age accelerates coronary microvascular dysfunction, particularly in women with angina and nonobstructive coronary arteries. This decline in coronary flow reserve (CFR) with age is linked to reduced hyperemic flow, not baseline transit time.

Area of Science:

  • Cardiovascular Medicine
  • Medical Physiology
  • Coronary Artery Disease

Background:

  • Angina with nonobstructive coronary arteries (ANOCA) is common.
  • Limited research exists on how age and sex affect coronary microvascular function in ANOCA patients.

Purpose of the Study:

  • To investigate the impact of age and sex on coronary microvascular function in patients with ANOCA.
  • To assess associations between age, sex, and key coronary physiologic indices.

Main Methods:

  • Invasive coronary function testing in 206 ANOCA patients.
  • Assessed vasoreactivity, coronary flow reserve (CFR), and index of microcirculatory resistance (IMR).
  • Used multivariable regression and sex-stratified analyses.

Main Results:

  • Increasing age correlated with decreased CFR and increased IMR and hyperemic mean transit time (Tmn).
  • Women had lower IMR and shorter Tmn but similar CFR compared to men.
  • Age-related IMR increase was significant in women, but not men; CFR decline with age was stronger in women.

Conclusions:

  • Age negatively impacts coronary microvascular function in ANOCA patients, with a more pronounced effect on microcirculatory resistance in women.
  • Age-related CFR decline is driven by reduced hyperemic flow, not baseline flow dynamics.
Abstract

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.3K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
183